|
|
||||||||||||||
|
|
|||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SHORT REPORT |
1 Department of Oncology, University Campus Bio-Medico, Rome, 00100 Italy
2 Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA 23230, USA
3 Institute of Cardiology, Catholic University, Rome, 00100 Italy
4 Department of Experimental Medicine and Pathology, University "La Sapienza", Rome, 00100 Italy
5 Institute of Pathologic Anatomy, University of Trieste, Trieste, 64100 Italy
6 Department of Forensic Medicine, Catholic University, Rome
7 Institute of Pathology, University of Torvergata, Rome, 00100 Italy
8 Department of Biochemistry, Section of Pathologic Anatomy, Second University of Naples, Naples, 28100 Italy
Correspondence to:
Dr A Baldi
Via G. Orsi, 26-Napoli, Italy; alfonsobaldi{at}tiscali.it
ABSTRACT
Background: Apoptosis is a key feature in postinfarction remodelling leading to progressive myocyte loss. Both proapoptotic and antiapoptotic factors contribute to the delicate balance between death and survival. The survivin pathway has emerged as essential in the control of apoptosis, although its role in heart disease is unknown.
Aim: To evaluate survivin expression after acute myocardial infarction (AMI).
Methods: Survivin expression was assessed immunohistochemically in the peri-infarct and remote viable myocardium in 17 consecutive patients who died 130 weeks after AMI and in four control hearts.
Results: Survivin was expressed by myocytes in the peri-infarct area in eight patients and in the remote region in 13 patients. The rate of survivin expression after AMI was significantly higher in the remote versus peri-infarct regions and compared with control hearts. Its expression was inversely associated with the presence of dilated cardiopathy and of apoptosis, independently from the gross pathology infarct size.
Conclusions: Survivin myocardial expression after AMI may be associated with the survival of at risk myocardium and may be indicative of more favourable remodelling after AMI. These findings identify a potential new target for the treatment of postinfarction remodelling.
Abbreviations: AMI, acute myocardial infarction; COX-2, cyclooxygenase 2; HIF-1
, hypoxia inducible factor 1
; LV, left ventricle
Keywords: survivin; apoptosis; heart failure; myocardial infarction
This article has been cited by other articles:
![]() |
B. Levkau, M. Schafers, J. Wohlschlaeger, K. von Wnuck Lipinski, P. Keul, S. Hermann, N. Kawaguchi, P. Kirchhof, L. Fabritz, J. Stypmann, et al. Survivin Determines Cardiac Function by Controlling Total Cardiomyocyte Number Circulation, March 25, 2008; 117(12): 1583 - 1593. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lechler, X. Wu, W. Bernhardt, V. Campean, S. Gastiger, T. Hackenbeck, B. Klanke, A. Weidemann, C. Warnecke, K. Amann, et al. The Tumor Gene Survivin Is Highly Expressed in Adult Renal Tubular Cells: Implications for a Pathophysiological Role in the Kidney Am. J. Pathol., November 1, 2007; 171(5): 1483 - 1498. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-L. Yao, Y.-G. Wang, W.-J. Cai, T. Yao, and Y.-C. Zhu Survivin mediates the anti-apoptotic effect of {delta}-opioid receptor stimulation in cardiomyocytes J. Cell Sci., March 1, 2007; 120(5): 895 - 907. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Hahn, H.-J. Cho, J.-W. Bae, H.-S. Yuk, K.-i. Kim, K.-W. Park, B.-K. Koo, I.-H. Chae, C.-S. Shin, B.-H. Oh, et al. beta-Catenin Overexpression Reduces Myocardial Infarct Size through Differential Effects on Cardiomyocytes and Cardiac Fibroblasts J. Biol. Chem., October 13, 2006; 281(41): 30979 - 30989. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| Journal of Clinical Pathology | Molecular Pathology |